176 related articles for article (PubMed ID: 22187075)
1. Freeze drying formulation using microscale and design of experiment approaches: a case study using granulocyte colony-stimulating factor.
Grant Y; Matejtschuk P; Bird C; Wadhwa M; Dalby PA
Biotechnol Lett; 2012 Apr; 34(4):641-8. PubMed ID: 22187075
[TBL] [Abstract][Full Text] [Related]
2. Rapid optimization of protein freeze-drying formulations using ultra scale-down and factorial design of experiment in microplates.
Grant Y; Matejtschuk P; Dalby PA
Biotechnol Bioeng; 2009 Dec; 104(5):957-64. PubMed ID: 19530082
[TBL] [Abstract][Full Text] [Related]
3. Basic Principles of Lyophilization, Part 2.
Akers MJ
Int J Pharm Compd; 2016; 20(1):20-7. PubMed ID: 27125053
[TBL] [Abstract][Full Text] [Related]
4. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
[TBL] [Abstract][Full Text] [Related]
5. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
Stärtzel P
J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
[TBL] [Abstract][Full Text] [Related]
6. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
7. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
Garidel P; Pevestorf B; Bahrenburg S
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations.
Liao YH; Brown MB; Martin GP
Eur J Pharm Biopharm; 2004 Jul; 58(1):15-24. PubMed ID: 15207533
[TBL] [Abstract][Full Text] [Related]
9. Effect of formulation and freeze-drying on the long-term stability of rDNA-derived cytokines.
Dawson PJ
Dev Biol Stand; 1992; 74():273-82; discussion 282-4. PubMed ID: 1592176
[TBL] [Abstract][Full Text] [Related]
10. Use of a temperature ramp approach (TRA) to design an optimum and robust freeze-drying process for pharmaceutical formulations.
Assegehegn G; Brito-de la Fuente E; Franco JM; Gallegos C
Int J Pharm; 2020 Mar; 578():119116. PubMed ID: 32027958
[TBL] [Abstract][Full Text] [Related]
11. Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations.
Trnka H; Rantanen J; Grohganz H
Pharm Dev Technol; 2015 Jan; 20(1):65-73. PubMed ID: 24417680
[TBL] [Abstract][Full Text] [Related]
12. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.
Izutsu KI
Adv Exp Med Biol; 2018; 1081():371-383. PubMed ID: 30288720
[TBL] [Abstract][Full Text] [Related]
13. Lyophilized Drug Product Cake Appearance: What Is Acceptable?
Patel SM; Nail SL; Pikal MJ; Geidobler R; Winter G; Hawe A; Davagnino J; Rambhatla Gupta S
J Pharm Sci; 2017 Jul; 106(7):1706-1721. PubMed ID: 28341598
[TBL] [Abstract][Full Text] [Related]
14. Stability study of drug-loaded proteinoid microsphere formulations during freeze-drying.
Ma X; Santiago N; Chen YS; Chaudhary K; Milstein SJ; Baughman RA
J Drug Target; 1994; 2(1):9-21. PubMed ID: 8069587
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the effects of buffer conditions and extremolytes on thermostability of granulocyte colony-stimulating factor using high-throughput screening combined with design of experiments.
Ablinger E; Hellweger M; Leitgeb S; Zimmer A
Int J Pharm; 2012 Oct; 436(1-2):744-52. PubMed ID: 22850292
[TBL] [Abstract][Full Text] [Related]
16. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.
Kamerzell TJ; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
Adv Drug Deliv Rev; 2011 Oct; 63(13):1118-59. PubMed ID: 21855584
[TBL] [Abstract][Full Text] [Related]
17. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone.
Pikal MJ; Dellerman K; Roy ML
Dev Biol Stand; 1992; 74():21-37; discussion 37-8. PubMed ID: 1592171
[TBL] [Abstract][Full Text] [Related]
18. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers.
De Beer TR; Wiggenhorn M; Hawe A; Kasper JC; Almeida A; Quinten T; Friess W; Winter G; Vervaet C; Remon JP
Talanta; 2011 Feb; 83(5):1623-33. PubMed ID: 21238761
[TBL] [Abstract][Full Text] [Related]
19. Basic Principles of Lyophilization, Part 1.
Akers MJ
Int J Pharm Compd; 2015; 19(6):471-6. PubMed ID: 26891561
[TBL] [Abstract][Full Text] [Related]
20. Lyophilization Process Design and Development: A Single-Step Drying Approach.
Pansare SK; Patel SM
J Pharm Sci; 2019 Apr; 108(4):1423-1433. PubMed ID: 30468830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
